Madras High Court via recent judgement dated March 28, 2024, in Genentech vs Controller Of Patents And Designs [(T)CMA(PT) No.57 of 2023 (OA/50/2020/PT/CHN)] addressed Genentech, Inc.’s appeal concerning the rejection of its patent application (No. 5832/CHENP/2014) for “Inhibitors of IAP”—organic compounds intended for cancer therapy.
Continue reading “Madras High Court on Patent Inventiveness, Hindsight and Comparative Data in Genentech Case”We are proud to share that our esteemed client, Kurkshetra University, has recently recognized the hard work and dedication of our Managing Founder – Dr. Ramesh Kr. Mehta, with a heartfelt letter of appreciation. His exceptional contributions in developing and building a robust Intellectual Property Rights (IPR) portfolio have been instrumental in shaping the innovative strategies that define our firm.
Continue reading “Honoring Excellence: A Letter of Appreciation from Kurkshetra University”The Madras High Court on February 8, 2024, in Techpolymers Industria E Comercio LTDA vs. The Deputy Controller of Patents and Designs [(T)CMA(PT)/180/2023, (OA/SR.11/2020/PT/CHN)], addressed the rejection of a patent application concerning thermoplastic polymers used in injection-molded articles.
Continue reading “Emphasizing Substantive Evaluation Over Semantics: Madras High Court Sets Aside Patent Rejection”
In the matter of Arthrogen GMBH (‘Appellant’) v Controller General of Patents, Designs and Trademarks and Anr (‘Respondents’) [C.A.(COMM.IPD-PAT) 415/2022], the Delhi High Court, vide its order dated 05.02.2024, set aside the Respondents impugned order dated 28th November 2019 and remanded the matter to the Respondents for de novo consideration while restoring the patent application for the subject patent to its original number.
Continue reading “Delhi High Court differentiates between a method of treatment and a method of producing a substance used for treatment”The President of India has promulgated the Tribunals Reforms (Rationalisation and Conditions of Service) Ordinance, 2021 on 04 April 2021 (“Ordinance”). The Ordinance has been brought to effect immediately.
In the context of Intellectual Property Laws, the present Ordinance has omitted references to “the Appellate Board” and substituted the same with the words “High Court” as applicable under the following statues:
Continue reading “With the Tribunal Reforms Ordinance of 2021, Appellate Boards for IP matters have been replaced by High Court”
Dr. Ramesh Kr. Mehta of Mehta & Mehta Associates (MehtaIP) was recently invited by National Agri-Food Biotechnology Institute (NABI) to speak on “Innovation in Biotechnology: Perspective of Patent Attorney” and interact with NABI and Center of Innovative and Applied Bioprocessing (CIAB)’s scientists on IP related Matters as part of their IPR Workshop held at NABI, Mohali. A few glimpses of the interactive session with NABI and CIAB’s scientists:
Continue reading “IPR Workshop at NABI, Mohali”We are pleased to share that Mehta & Mehta Associates (MehtaIP) has been listed by The Legal 500 (Legalease) in the Legal 500 Asia Pacific rankings 2021 as Leading Firm and our members Dr. Ramesh Kr. Mehta, Ankush Mehta, Abhilasha Niroola and Akshay Mehta have been listed as Recommended Lawyers in the Legal 500 Asia Pacific rankings 2021.
Continue reading “Announcement – Recognition by ‘Legal 500’”The domain of Artificial Intelligence (AI) is rapidly advancing and finding new utility frequently. It continues to overhaul on how to approach and solve problems in a wide variety of fields.
Continue reading “Artificial Intelligence (AI) as an Inventor: Indian Perspective”
MehtaIP 